CD274 and Merkel cell skin cancer: Immune checkpoint inhibitors (ICIs), including programmed death-ligand 1 (PD-L1) inhibitors such as avelumab, have transformed the treatment of cancers, including Merkel cell carcinoma (MCC), urothelial carcinoma, and renal cell carcinoma.